120 related articles for article (PubMed ID: 4047949)
1. [Treatment of neoplastic pleural effusion by intrapleural administration of Corynebacterium parvum vaccine].
Krasucka-Kluźniak A; Krakówka P
Pneumonol Pol; 1985 May; 53(5):240-7. PubMed ID: 4047949
[No Abstract] [Full Text] [Related]
2. Treatment of malignant pleural effusions with intrapleural Corynebacterium parvum or tetracycline.
Leahy BC; Honeybourne D; Brear SG; Carroll KB; Thatcher N; Stretton TB
Eur J Respir Dis; 1985 Jan; 66(1):50-4. PubMed ID: 3979476
[TBL] [Abstract][Full Text] [Related]
3. Treatment of malignant pleural effusions with intracavitary Corynebacterium parvum.
Casali A; Gionfra T; Rinaldi M; Tonachella R; Tropea F; Venturo I; De Martino C; Curcio CG
Cancer; 1988 Aug; 62(4):806-11. PubMed ID: 3293763
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the effectiveness and adverse effects of a Corynebacterium parvum vaccine made in Czechoslovakia with Coparvax, a British preparation made by Wellcome, in the treatment of malignant pleural effusions].
Marel M; Melínová L; Bednár M
Cas Lek Cesk; 1989 Aug; 128(34):1071-4. PubMed ID: 2790915
[TBL] [Abstract][Full Text] [Related]
5. [Monitoring natural killer cell activity in the blood of patients with malignant pleural effusion after intrapleural administration of Corynebacterium parvum].
Marel M; Pospísil M; Fiserová A; Melínová L; Skácel Z; Bednár M
Cas Lek Cesk; 1990 Apr; 129(16):498-500. PubMed ID: 2340567
[TBL] [Abstract][Full Text] [Related]
6. [Anatomical study of the fibrosing action of Corynebacterium parvum in malignant pleural effusion].
Foresti V; Scolari N; Villa A; Parisio E
Minerva Med; 1989 Oct; 80(10):1069-72. PubMed ID: 2812462
[TBL] [Abstract][Full Text] [Related]
7. Comparison of efficacy of mitomycin-C and corynebacterium parvum in the management of malignant pleural effusion.
Yew WW; Chan SL; Kwan SY
Chin Med J (Engl); 1988 Oct; 101(10):737-9. PubMed ID: 3150706
[No Abstract] [Full Text] [Related]
8. Coparvax for malignant effusion?
Drug Ther Bull; 1983 Oct; 21(20):79-80. PubMed ID: 6641514
[No Abstract] [Full Text] [Related]
9. Lung cancer patients treated with Corynebacterium parvum. Phase I toxicity study.
Yadeau R; Bates HA; Fortuny I
Minn Med; 1979 Sep; 62(9):673-5. PubMed ID: 503003
[No Abstract] [Full Text] [Related]
10. Corynebacterium parvum in malignant pleural effusion. A randomized prospective study.
Hillerdal G; Kiviloog J; Nöu E; Steinholtz L
Eur J Respir Dis; 1986 Sep; 69(3):204-6. PubMed ID: 2430825
[TBL] [Abstract][Full Text] [Related]
11. [Pleural effusion. Local treatment by Corynebacterium parvum].
Serrou B; Cupissol D
Nouv Presse Med; 1980 Jun; 9(25):1777-8. PubMed ID: 7383874
[No Abstract] [Full Text] [Related]
12. Treatment of malignant ascitic and pleural effusion with Corynebacterium parvum.
Webb HE; Oaten SW; Pike CP
Br Med J; 1978 Feb; 1(6109):338-40. PubMed ID: 623981
[TBL] [Abstract][Full Text] [Related]
13. [The use of Corynebacterium parvum in pleurodesis].
Helin T; Haahtela T
Duodecim; 1988; 104(4):262-5. PubMed ID: 3168834
[No Abstract] [Full Text] [Related]
14. Prolonged fever after pleural instillation of Corynebacterium parvum (Coparvax).
Laroche CM; Britton M
Thorax; 1987 Oct; 42(10):823-4. PubMed ID: 3424259
[No Abstract] [Full Text] [Related]
15. Symptomatic treatment of recurrent malignant pleural effusions with intrapleurally administered Corynebacterium parvum. Clinical response is not associated with evidence of enhancement of local cellular-mediated immunity.
Rossi GA; Felletti R; Balbi B; Sacco O; Cosulich E; Risso A; Melioli G; Ravazzoni C
Am Rev Respir Dis; 1987 Apr; 135(4):885-90. PubMed ID: 2436513
[TBL] [Abstract][Full Text] [Related]
16. Intrapleural Corynebacterium parvum.
Costello J
Br J Hosp Med; 1987 Aug; 38(2):149-50. PubMed ID: 3651650
[No Abstract] [Full Text] [Related]
17. Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions.
Millar JW; Hunter AM; Horne NW
Thorax; 1980 Nov; 35(11):856-8. PubMed ID: 7221983
[TBL] [Abstract][Full Text] [Related]
18. Intrapleural Corynebacterium parvum for malignant pleural effusions.
Felletti R; Ravazzoni C
Thorax; 1983 Jan; 38(1):22-4. PubMed ID: 6845257
[TBL] [Abstract][Full Text] [Related]
19. Chemoimmunotherapy (DTIC and Corynebacterium parvum) for disseminated malignant melanoma.
Karakousis CP; Didolkar MS; Han T
Cancer Treat Rep; 1981; 65(9-10):925-6. PubMed ID: 7273032
[No Abstract] [Full Text] [Related]
20. Acute polyarthritis following the use of Corynebacterium parvum vaccine (Coparvax) for malignant pleural effusion.
Lever AM; Forsythe J; Oxford P
Postgrad Med J; 1983 Dec; 59(698):799-800. PubMed ID: 6657546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
